Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company's issued and outstanding common shares. As…

Psyence BioMed shrinks share count from 6,388,604 to 1,022,177

Trading in post-consolidation shares begins Feb. 2 as every 6.25 Psyence BioMed shares combine into one, reducing shares outstanding to 1,022,177.